Podcasts

In this practical, case-based discussion, a breast oncology pharmacist and nurse practitioner walk through how they anticipate and…

Pulmonary fibrosis remains one of the most challenging respiratory diseases – often underdiagnosed, undertreated, and misunderstood…

How do urologists, oncologists, and advanced practice providers coordinate care in muscle-invasive bladder cancer…

Join us for this two-episode mini-series featuring lead study authors, Mario Castro and Njira Lugogo, as they discuss key findings from the…

David Heymann, global health leader and professor of infectious disease epidemiology, shares lessons from Ebola, SARS, smallpox, and the future of pandemic preparedness.

In this special two-part Hema Now episode, Catherine Glass highlights 2025’s guests, from congress leaders to pioneering, leading global hematology clinicians and researchers.

In this series, host Saranya Ravindran speaks with Lisa Saiman about the global threat of microbial infection and resistance in patients with cystic fibrosis.

Anna Minchom, Clinical Scientist in the Drug Development Unit at the Royal Marsden Hospital, explains the drug development process, key considerations in designing and conducting a trial, and the challenges in drug resistance.